Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-24T00:07:09.805Z Has data issue: false hasContentIssue false
  • English
  • Français

Substance use in individuals at clinical high risk of psychosis

Published online by Cambridge University Press:  02 March 2015

L. Buchy ,
K. S. Cadenhead ,
T. D. Cannon ,
B. A. Cornblatt ,
T. H. McGlashan ,
D. O. Perkins ,
L. J. Seidman ,
M. T. Tsuang ,
E. F. Walker  and
S. W. Woods
...Show all authors
L. Buchy
Affiliation:
Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada
K. S. Cadenhead
Affiliation:
Department of Psychiatry, UCSD, San Diego, CA, USA
T. D. Cannon
Affiliation:
Department of Psychology, Yale University, New Haven, CT, USA
B. A. Cornblatt
Affiliation:
Department of Psychiatry, Zucker Hillside Hospital, Long Island, NY, USA
T. H. McGlashan
Affiliation:
Department of Psychiatry, Yale University, New Haven, CT, USA
D. O. Perkins
Affiliation:
Department of Psychiatry, University of North Carolina, Chapel Hill, NC, USA
L. J. Seidman
Affiliation:
Department of Psychiatry, Harvard Medical School at Beth Israel Deaconess Medical Center and Massachusetts General Hospital, Boston, MA, USA
M. T. Tsuang
Affiliation:
Department of Psychology, Yale University, New Haven, CT, USA
E. F. Walker
Affiliation:
Departments of Psychology and Psychiatry, Emory University, Atlanta, GA, USA
S. W. Woods
Affiliation:
Department of Psychiatry, Yale University, New Haven, CT, USA
R. Heinssen
Affiliation:
Schizophrenia Spectrum Research Program, Division of Adult Translational Research, National Institute of Mental Health, Bethesda, MD, USA
C. E. Bearden
Affiliation:
Departments of Psychiatry and Biobehavioral Sciences and Psychology, UCLA, Los Angeles, CA, USA
D. Mathalon
Affiliation:
Departments of Psychiatry, University of California, San Francisco, San Francisco, CA, USA
J. Addington*
Affiliation:
Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada
*
* Address for correspondence: J. Addington, Mathison Centre for Mental Health Research and Education, University of Calgary, 3280 Hospital Drive NW, Calgary, Alberta, CanadaT2N 4Z6. (Email: [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

A series of research reports has indicated that the use of substances such as cannabis, alcohol and tobacco are higher in youth at clinical high risk (CHR) of developing psychosis than in controls. Little is known about the longitudinal trajectory of substance use, and findings on the relationship between substance use and later transition to psychosis in CHR individuals are mixed.

Method

At baseline and 6- and 12-month follow-ups, 735 CHR and 278 control participants completed the Alcohol and Drug Use Scale and a cannabis use questionnaire. The longitudinal trajectory of substance use was evaluated with linear mixed models.

Results

CHR participants endorsed significantly higher cannabis and tobacco use severity, and lower alcohol use severity, at baseline and over a 1-year period compared with controls. CHR youth had higher lifetime prevalence and frequency of cannabis, and were significantly younger upon first use, and were more likely to use alone and during the day. Baseline substance use did not differentiate participants who later transitioned to psychosis (n = 90) from those who did not transition (n = 272). Controls had lower tobacco use than CHR participants with a prodromal progression clinical outcome and lower cannabis use than those with a psychotic clinical outcome at the 2-year assessment.

Conclusions

In CHR individuals cannabis and tobacco use is higher than in controls and this pattern persists across 1 year. Evaluation of clinical outcome may provide additional information on the longitudinal impact of substance use that cannot be detected through evaluation of transition/non-transition to psychosis alone.

Keywords

Alcoholcannabisprodromesubstance usetobacco
Type
Original Articles
Information
Psychological Medicine , Volume 45 , Issue 11 , August 2015 , pp. 2275 - 2284
Copyright
Copyright © Cambridge University Press 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Addington, J, Addington, D (2007). Patterns, predictors and impact of substance use in early psychosis: a longitudinal study. Acta Psychiatrica Scandinavica 115, 304–309.CrossRefGoogle ScholarPubMed
Addington, J, Cadenhead, KS, Cornblatt, BA, Mathalon, DH, McGlashan, TH, Perkins, DO, Seidman, LJ, Tsuang, MT, Walker, EF, Woods, SW, Addington, JA, Cannon, TD (2012). North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophrenia Research 142, 77–82.CrossRefGoogle ScholarPubMed
Addington, J, Case, N, Saleem, MM, Auther, AM, Cornblatt, BA, Cadenhead, KS (2014). Substance use in clinical high risk for psychosis: a review of the literature. Early Intervention in Psychiatry 8, 104–112.CrossRefGoogle ScholarPubMed
Arseneault, L, Cannon, M, Poulton, R, Murray, R, Caspi, A, Moffitt, TE (2002). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 325, 1212–1213.CrossRefGoogle ScholarPubMed
Auther, AM, McLaughlin, D, Carrion, RE, Nagachandran, P, Correll, CU, Cornblatt, BA (2012). Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome. Psychological Medicine 42, 2485–2497.CrossRefGoogle ScholarPubMed
Barnett, JH, Werners, U, Secher, SM, Hill, KE, Brazil, R, Masson, K, Pernet, DE, Kirkbride, JB, Murray, GK, Bullmore, ET, Jones, PB (2007). Substance use in a population-based clinic sample of people with first-episode psychosis. British Journal of Psychiatry 190, 515–520.CrossRefGoogle Scholar
Buchy, L, Perkins, D, Woods, SW, Liu, L, Addington, J (2014). Impact of substance use on conversion to psychosis in youth at clinical high risk of psychosis. Schizophrenia Research 156, 277–280.CrossRefGoogle ScholarPubMed
Cannon, TD, Cadenhead, K, Cornblatt, B, Woods, SW, Addington, J, Walker, E, Seidman, LJ, Perkins, D, Tsuang, M, McGlashan, T, Heinssen, R (2008). Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Archives of General Psychiatry 65, 28–37.CrossRefGoogle ScholarPubMed
Caspi, A, Moffitt, TE, Cannon, M, McClay, J, Murray, R, Harrington, H, Taylor, A, Arseneault, L, Williams, B, Braithwaite, A, Poulton, R, Craig, IW (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene x environment interaction. Biological Psychiatry 57, 1117–1127.CrossRefGoogle ScholarPubMed
Clausen, L, Hjorthoj, CR, Thorup, A, Jeppesen, P, Petersen, L, Bertelsen, M, Nordentoft, M (2014). Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial. Psychological Medicine 44, 117–126.CrossRefGoogle ScholarPubMed
Compton, MT, Kelley, ME, Ramsay, CE, Pringle, M, Goulding, SM, Esterberg, ML, Stewart, T, Walker, EF (2009). Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients. American Journal of Psychiatry 166, 1251–1257.CrossRefGoogle ScholarPubMed
Cooper, J, Mancuso, SG, Borland, R, Slade, T, Galletly, C, Castle, D (2012). Tobacco smoking among people living with a psychotic illness: the second Australian Survey of Psychosis. Australian and New Zealand Journal of Psychiatry 46, 851–863.CrossRefGoogle ScholarPubMed
Corcoran, CM, Kimhy, D, Stanford, A, Khan, S, Walsh, J, Thompson, J, Schobel, S, Harkavy-Friedman, J, Goetz, R, Colibazzi, T, Cressman, V, Malaspina, D (2008). Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis. Schizophrenia Research 106, 286–293.CrossRefGoogle ScholarPubMed
Dancey, C, Reidy, J (2004). Statistics without Maths for Psychology: using SPSS for Windows. Prentice Hall: London.Google Scholar
Dragt, S, Nieman, DH, Becker, HE, van de Fliert, R, Dingemans, PM, de Haan, L, van Amelsvoort, TA, Linszen, DH (2010). Age of onset of cannabis use is associated with age of onset of high-risk symptoms for psychosis. Canadian Journal of Psychiatry 55, 165–171.CrossRefGoogle ScholarPubMed
Dragt, S, Nieman, DH, Schultze-Lutter, F, van der Meer, F, Becker, H, de Haan, L, Dingemans, PM, Birchwood, M, Patterson, P, Salokangas, RK, Heinimaa, M, Heinz, A, Juckel, G, Graf von Reventlow, H, French, P, Stevens, H, Ruhrmann, S, Klosterkötter, J, Linszen, DH; EPOS Group (2012). Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis. Acta Psychiatrica Scandinavica 125, 45–53.CrossRefGoogle ScholarPubMed
Drake, RE, Mueser, K, McHugo, G (1996). Clinical rating scales. In Outcomes Assessment in Clinical Practice (ed. Sederer, L. and Dickey, B.), pp. 113–116. Williams and Wilkins: Baltimore.Google Scholar
First, MB, Spitzer, RL, Gibbon, M, Williams, JBW (1998). Structured Clinical Interview for DSM-IV Patient Edition (SCID-I/P V and SCID-I/NP Version 2.0). Biometric Research Department: New York.Google Scholar
Fusar-Poli, P, Bonoldi, I, Yung, AR, Borgwardt, S, Kempton, MJ, Valmaggia, L, Barale, F, Caverzasi, E, McGuire, P (2012). Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Archives of General Psychiatry 69, 220–229.CrossRefGoogle ScholarPubMed
Gill, KE, Poe, L, Azimov, N, Ben-David, S, Vadhan, NP, Girgis, R, Moore, H, Cressman, V, Corcoran, CM (2013). Reasons for cannabis use among youths at ultra high risk for psychosis. Early Intervention in Psychiatry. Published online 26 November 2013. doi:10.1111/eip.12112 Google ScholarPubMed
Henquet, C, Di Forti, M, Morrison, P, Kuepper, R, Murray, RM (2008). Gene–environment interplay between cannabis and psychosis. Schizophrenia Bulletin 34, 1111–1121.CrossRefGoogle ScholarPubMed
Henquet, C, Krabbendam, L, Spauwen, J, Kaplan, C, Lieb, R, Wittchen, HU, van Os, J (2005). Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 330, 11.CrossRefGoogle ScholarPubMed
Kolliakou, A, Joseph, C, Ismail, K, Atakan, Z, Murray, RM (2011). Why do patients with psychosis use cannabis and are they ready to change their use? International Journal of Developmental Neuroscience 29, 335–346.CrossRefGoogle ScholarPubMed
Korver, N, Nieman, DH, Becker, HE, van de Fliert, JR, Dingemans, PH, de Haan, L, Spiering, M, Schmitz, N, Linszen, DH (2010). Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls. Australian and New Zealand Journal of Psychiatry 44, 230–236.CrossRefGoogle ScholarPubMed
Kristensen, K, Cadenhead, KS (2007). Cannabis abuse and risk for psychosis in a prodromal sample. Psychiatry Research 151, 151–154.CrossRefGoogle Scholar
Kuepper, R, van Os, J, Lieb, R, Wittchen, HU, Hofler, M, Henquet, C (2011). Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ 342, d738.CrossRefGoogle ScholarPubMed
Machielsen, M, van der Sluis, S, de Haan, L (2010). Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms. Australian and New Zealand Journal of Psychiatry 44, 721–728.CrossRefGoogle ScholarPubMed
McGlashan, TH, Walsh, BC, Woods, SW (2010). The Psychosis Risk Syndrome: Handbook for Diagnosis and Follow-up. Oxford University Press: New York.Google Scholar
Miller, WR, Tonigan, JS (1996). Assessing drinkers’ motivation for change: the Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES). Psychology of Addictive Behaviors 10, 81–89.CrossRefGoogle Scholar
Moore, TH, Zammit, S, Lingford-Hughes, A, Barnes, TR, Jones, PB, Burke, M, Lewis, G (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370, 319–328.CrossRefGoogle ScholarPubMed
Phillips, LJ, Curry, C, Yung, AR, Yuen, HP, Adlard, S, McGorry, PD (2002). Cannabis use is not associated with the development of psychosis in an ‘ultra’ high-risk group. Australian and New Zealand Journal of Psychiatry 36, 800–806.CrossRefGoogle ScholarPubMed
Regier, DA, Farmer, ME, Rae, DS, Locke, BZ, Keith, SJ, Judd, LL, Goodwin, FK (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264, 2511–2518.CrossRefGoogle ScholarPubMed
Ruhrmann, S, Schultze-Lutter, F, Salokangas, RK, Heinimaa, M, Linszen, D, Dingemans, P, Birchwood, M, Patterson, P, Juckel, G, Heinz, A, Morrison, A, Lewis, S, von Reventlow, HG, Klosterkotter, J (2010). Prediction of psychosis in adolescents and young adults at high risk: results from the Prospective European Prediction of Psychosis Study. Archives of General Psychiatry 67, 241–251.CrossRefGoogle Scholar
Spencer, C, Castle, D, Michie, PT (2002). Motivations that maintain substance use among individuals with psychotic disorders. Schizophrenia Bulletin 28, 233–247.CrossRefGoogle ScholarPubMed
Stowkowy, J, Addington, J (2013). Predictors of a clinical high risk status among individuals with a family history of psychosis. Schizophrenia Research 147, 281–286.CrossRefGoogle ScholarPubMed
Thompson, A, Nelson, B, Yung, A (2011). Predictive validity of clinical variables in the “at risk” for psychosis population: international comparison with results from the North American Prodrome Longitudinal Study. Schizophrenia Research 126, 51–57.CrossRefGoogle ScholarPubMed
Thornton, LK, Baker, AL, Johnson, MP, Kay-Lambkin, F, Lewin, TJ (2012). Reasons for substance use among people with psychotic disorders: method triangulation approach. Psychology of Addictive Behaviors 26, 279–288.CrossRefGoogle ScholarPubMed
Wechsler, D (1999). Wechsler Abbreviated Scale of Intelligence. The Psychological Corporation: San Antonio, TX.Google Scholar